BOSTON — Nelson marks the second branded player that should be making a significant commitment against iron supplementation in the coming year — the other being Meda Pharmaceuticals.
Nelson, however, is approaching the market with a "less is more" mantra. In other words, it's a lower dose iron solution with a higher aborption rate.
And because of the lower iron dose, it'll be a lot less likely to cause constipation and will be gentler on the stomach too.